Antibodies against epidermal growth factor receptor (egfr) and uses thereof

Abstract

Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.

What is claimed is: 
     
         1 . A composition comprising isolated monoclonal anti-EGFR antibody vb, comprising heavy chain SEQ ID NO: 10 and light chain SEQ ID NO: 21, in a pharmaceutically acceptable carrier. 
     
     
         2 . A composition comprising isolated monoclonal anti-EGFR antibody vj, comprising heavy chain SEQ ID NO: 8 and light chain SEQ ID NO: 19, in a pharmaceutically acceptable carrier. 
     
     
         3 . A composition comprising isolated monoclonal anti-EGFR antibody vf, comprising heavy chain SEQ ID NO: 3 and light chain SEQ ID NO: 14, in a pharmaceutically acceptable carrier.